Record ID | marc_columbia/Columbia-extract-20221130-030.mrc:152842268:3795 |
Source | marc_columbia |
Download Link | /show-records/marc_columbia/Columbia-extract-20221130-030.mrc:152842268:3795?format=raw |
LEADER: 03795cam a2200781 i 4500
001 14762636
005 20220403002120.0
006 m o d
007 cr |||||||||||
008 191123s2020 flu ob 001 0 eng
010 $a 2019026377
035 $a(OCoLC)on1130379655
035 $a(NNC)14762636
040 $aDLC$beng$erda$cDLC$dTYFRS$dOCLCF$dDLC$dOCLCO$dAU@$dYDX$dN$T$dOCLCO$dOCLCQ$dOCLCA$dOCLCO
019 $a1145940643
020 $a9780429275067$q(pdf)
020 $a0429275064
020 $z9780367224769$q(Hardback)
020 $a9781000710816$q(electronic bk. : EPUB)
020 $a1000710815$q(electronic bk. : EPUB)
020 $a9781000710038$q(electronic bk. : PDF)
020 $a1000710033$q(electronic bk. : PDF)
020 $z0367224763
035 $a(OCoLC)1130379655$z(OCoLC)1145940643
037 $a9780429275067$bTaylor & Francis
042 $apcc
050 00 $aRM301.27
060 4 $aQV 771
072 7 $aMAT$x029000$2bisacsh
072 7 $aMED$x071000$2bisacsh
072 7 $aREF$x000000$2bisacsh
072 7 $aPBT$2bicssc
082 00 $a615.1072/4$223
049 $aZCUA
100 1 $aChow, Shein-Chung,$d1955-$eauthor.
245 10 $aInnovative statistics in regulatory science /$cShein-Chung Chow.
264 1 $aBoca Raton :$bCRC/CRC Press, Taylor & Francis Group,$c[2020]
300 $a1 online resource.
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
490 1 $aChapman & Hall/CRC biostatistics series
504 $aIncludes bibliographical references and index.
505 0 $aTotality-of-the-evidence -- Hypotheses testing versus confidence interval -- Endpoint selection -- Non-inferiority margin -- Missing data -- Multiplicity -- Sample size -- Reproducible research -- Extrapolation -- Consistency evaluation -- Drug products with multiple components -- Adaptive trial design -- Selection criteria in adaptive dose finding -- Generic drugs and biosimilars -- Precision and personalized medicine -- Big data analytics -- Rare disease drug development.
520 $a"The proposed book will focus on practical issues in pharmaceutical/clinical research and development from both regulatory and scientific perspectives. The book will outline and clarify those issues that have been commonly misused in the subject area of regulatory science"--$cProvided by publisher.
588 $aDescription based on online resource; title from PDF title page (Site, viewed 01/22/2021).
650 0 $aDrugs$xTesting.
650 0 $aClinical trials$xStatistical methods.
650 0 $aPharmacy$xResearch.
650 0 $aResearch$xStatistical methods.
650 0 $aDrugs.
650 2 $aPharmaceutical Preparations
650 6 $aMédicaments$xEssais cliniques.
650 6 $aÉtudes cliniques$xMéthodes statistiques.
650 6 $aRecherche$xMéthodes statistiques.
650 6 $aMédicaments.
650 7 $aMATHEMATICS / Probability & Statistics / General$2bisacsh
650 7 $aMEDICAL / Pharmacology$2bisacsh
650 7 $aREFERENCE / General$2bisacsh
650 7 $aClinical trials$xStatistical methods.$2fast$0(OCoLC)fst00864440
650 7 $aDrugs$xTesting.$2fast$0(OCoLC)fst00898940
650 7 $aPharmacy$xResearch.$2fast$0(OCoLC)fst01060314
650 7 $aResearch$xStatistical methods.$2fast$0(OCoLC)fst01095242
655 4 $aElectronic books.
776 08 $iPrint version:$aChow, Shein-Chung, 1955-$tStatistics in regulatory science$dBoca Raton : CRC/CRC Press, Taylor & Francis Group, [2020]$z9780367224769$w(DLC) 2019026376
830 0 $aChapman & Hall/CRC biostatistics series.
856 40 $uhttp://www.columbia.edu/cgi-bin/cul/resolve?clio14762636$zTaylor & Francis eBooks
852 8 $blweb$hEBOOKS